Nonetheless, our findings indicate a general trend towards higher TLR4 expression being associated with favorable OS outcomes in stage IV CRC suggesting its ability to induce immunogenic cell death is critical in CRC prognosis. This evidence concerns the gene TLR4 and colorectal carcinoma.